Feature | Artificial Intelligence | June 10, 2019 | By Greg Freiherr

DeepAAA Uses AI to Look Automatically For Aneurysms

SIIM Presentation to Highlight Potential of Artificial Intelligence

The DeepAAA algorithm, developed at the MGH & BWH Center for Clinical Data Science, accurately detected and measured an abdominal aortic aneurysm (AAA) in a CT image even though appearance of the AAA was complicated by a blood clot

The DeepAAA algorithm, developed at the MGH & BWH Center for Clinical Data Science, accurately detected and measured an abdominal aortic aneurysm (AAA) in a CT image even though appearance of the AAA was complicated by a blood clot. (The algorithm drew a green circle around the aneurysm.) Image courtesy of Varun Buch, MGH & BWH Center for Clinical Data Science

Editor’s note: This article is the second in a content series by Greg Freiherr covering the Society for Imaging Informatics in Medicine (SIIM) conference in June.

Aneurysms of the abdominal aorta may occur in elderly men. They can burst suddenly, killing more than 90 percent. Yet abdominal aortic aneurysms (AAAs) typically are asymptomatic. Often they are found during imaging exams performed for other reasons.

This tendency toward incidental discovery in the context of their prevalence and potential lethality led to the development of DeepAAA, an algorithm that uses artificial intelligence (AI) to search pelvic and abdominal CTs for signs of an abdominal aortic aneurysm.

“The idea (behind DeepAAA) is that if you’re using an algorithm that can work automatically in the background, you can screen for these aneurysms automatically,” said Mark H. Michalski, M.D., executive director of the Center for Clinical Data Science, which is operated jointly by the Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) in Boston.

Spotting patients at risk of complications from a burst abdominal aneurysm is one — but not the only — reason Michalski and his team at the MGH & BWH Center for Clinical Data Science developed DeepAAA. Another is to understand why AAAs only threaten the lives of some patients with this type of aneurysm.

“Sometimes it never progresses. Sometimes it progresses fast,” he said. “Understanding early who will progress would be really useful.”

 

SIIM presentation

DeepAAA has successfully identified potentially troublesome abdominal aortas, even when blood clots made discovery of the widening blood vessel difficult, Michalski said. The MGH/BWH team plans to formally report their findings during a scientific session Friday, June 28 at the annual meeting of the Society for Imaging Informatics in Medicine (SIIM).

DeepAAA is already in use at MGH and BWH to automatically search for AAAs. The resulting information may signal needed patient follow-up. It may also identify risk factors. Research on these factors may lead to the discovery of biomarkers “that can tell you what kind of patients are likely to rupture or which patients are most likely to progress,” Michalski said.

Currently known risk factors include age (elderly), gender (male); cigarette smoking, and hypertension. “But (an aneurysm) can happen to anyone,” he said.

 

Productizing AI Algorithms

The algorithm might have commercial prospects. The Center for Clinical Data Science is exploring strategic alliances with companies that might productize DeepAAA, according to Michalski, who explained that the Center seeks to demonstrate the potential of the AI algorithms, then hopes to hand them off to companies for productization.

“Partnerships with them are really important,” he said. “We don’t intend to build a sales force and we can’t be sure of the quality of these models across multiple sites. That is what the vendors do very effectively.”

DeepAAA is just one of several AI-infused algorithms being developed by the center. Others automatically check head CTs for stroke or hemorrhage. None is perfect, Michalski said. “But because we are at a big academic medical center, people understand that and they can help us improve these models on-the-fly.”

In the coming weeks, a software team at the center will begin making the adjustments that will fit these algorithms into clinical workflows, the metaphorical equivalent of fitting handles to shovels.

These “handles” might allow the AI-algorithms to be used in PACS or in CT scanners dedicated to hospital emergency departments, according to Michalski. The algorithms must also be integrated into the reporting or ordering systems “to help integrate (findings) into your report and to prompt you to do follow-up exams,” he said.

But many challenges remain. One involves training. When training DeepAAA, for example, developers must consider that abdominal aortas look different in different people. Some have a lot of curves; others have calcifications. And structures around and in the aorta (e.g., blood clots) can complicate automatic measurement of the blood vessel perimeter, which is essential if the early signs of AAAs are to be identified.

“The process by which we created this model (DeepAAA) — and validated it across several hundred additional and different cases — showed us that indeed the model works and can perform well,” he said.

 

Proven Feasibility

Michalski noted to Imaging Technology News (ITN) that this only proves “feasibility.” Productization may require the inclusion of a “function” at the clinical interface that allows the model to be tuned to patient populations other than the ones at the large academic center where DeepAAA was developed. This function may allow the addition of data representative of local patient populations, Michalski said.

Such additional training, which will involve deep learning, may take only a few months. But the additional images would have to be clearly labeled as indicating the presence of AAA.

In the meantime, the center is expanding the mission of DeepAAA to the thorax to look for signs of aortic aneurysms in chest CTs. Although these aneurysms occur less frequently than AAAs, they are also silent and, if they burst, can lead to medical complications or death.

 

Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, he has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

 

Related content:

Making AI Safe, Effective and Humane for Imaging

How Artificial Intelligence Can Predict and Detect Stroke

Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer 

Video: Technology Report: Artificial Intelligence 2018 

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 07, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
News | Artificial Intelligence | April 02, 2020
April 2, 2020 — In the face of the COVID-19 pand
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Lung infections generated by the coronavirus can be detected in...